U.S. President Joe Biden on Monday signed an executive order implementing a new initiative aiming to boost biomanufacturing in pharmaceuticals.The initiative aims to help expand U.S. biomanufacturing capabilities and reduce reliance on China.According to people familiar with the matter, the order la
Despite the sluggish initial public offering (IPO) market continuing throughout the year, four Korean biotech companies are preparing to go public in September. The four companies are SunBio, RP Bio, Plasmapp, and Shaperon.Most biopharmaceutical companies that went public in the first half suffered
Helixmith has made public the topline data of the phase 2a clinical trial of Engensis (VM202), its genetic treatment candidate for amyotrophic lateral sclerosis (ALS).In a public notice last Friday, Helixmith said it had received the topline data of phase 2a trials of VM202 on patients from its cont
HLB’s investigational anticancer drug, rivoceranib, proved the safety as a second-line treatment in gastric cancer in a phase 1 trial, according to an abstract partially released before the annual meeting of the European Society for Medical Oncology this Friday.The abstract includes results from a K
The one-year grace period granted to Kolon TissueGene has ended. The securities authorities suspended the company’s stock transaction over the past year due to controversy over unwarranted ingredient change in Invossa, the world’s first osteoarthritis cell genetic treatment.In a public notice on Wed
Eyegene Inc., which is developing messenger-RNA Covid-19 vaccine, said it would conduct clinical trials in the South African Republic, following Korea and Australia.In a public notice on Thursday, the company said it had won approval from SAHPRA, the South African Republic's health industry regulato
AbClon, a Kosdaq-listed biotech firm, said it registered its technology patent related to chimeric antigen receptor (CAR)-T cell therapy in the U.S. and Canada, respectively.In the U.S., AbClon registered the patent on its switchable CAR-T platform technology, applicable in AT501 for ovarian cancer.
Researchers from Korea Advanced Institute of Science and Technology (KAIST) and Seoul National University Bundang Hospital (SNUBH) said on Wednesday that they discovered a biomarker for osteoarthritis called mitochondrial double-stranded RNA (mt-dsRNA).Osteoarthritis occurs when the joint cartilage
NeoImmuneTech said it would disclose the interim results of a trial of NT-I7 (efineptakin alfa), a T-cell amplifier, in combination with an immune checkpoint inhibitor at the annual meeting of the Society for Immunotherapy of Cancer (SITC) in the U.S. in November.NeoImmuneTech’s study was selected a
Celltrion said it would release the results of phase 3 trials of two biosimilars at two European conferences in September.The two biosimilars are CT-P43 referencing Stelara (ingredient: ustekinumab) and Vegzelma (bevacizumab) referencing Avastin.During the 31st European Academy of Dermatology and Ve
A joint research team, including the Catholic University of Korea, Catholic Medical Center (CMC), has developed a holographic microscope to observe a living mouse’s brain neural networks at 3D high resolution without removing its skull.Light visualizing deep body tissues requires accurate measuremen
GC Labs said Monday that it welcomed three infectious disease experts from Ethiopia and Tanzania participating in its tuberculosis program (TB) as part of the 2022 Lee Jong-wook Fellowship Program for disease research specialists.The "Lee Jong-wook Fellowship" is a training program provided by the K
GI Cell said Monday that they signed a research and development collaboration agreement with HK inno.N to develop allogenic CAR-NK candidates and advance the development of numerous CAR-NK therapies.CAR-NK (Chimeric antigen receptor-natural killer) therapy is a novel immunotherapy strategy that util
VaxCell Biotherapeutics said it would end its dendritic cell clinical trial of Vax-DC/MM and step up efforts to develop CAR-MIL as an alternative treatment for multiple myeloma.Existing treatments for multiple myeloma have shown limitations. For instance, there are a wide variety of antigens that ca
MSD Korea celebrated expanded insurance benefits for its anti-PD-1 immuno-cancer drug, Keytruda, for the secondary treatment of bladder cancer patients who failed in platinum-containing chemotherapy treatments in an online news conference Tuesday.In a presentation titled "UC (You see) more tomorrows
The Korea Advanced Institute of Science and Technology (KAIST) said Monday that its research team has developed a new type of protein treatment to reduce the side effects, including severe inflammation, from existing Alzheimer's treatments.Alzheimer's disease is the leading cause of senile dementia
HanAll Biopharma said it has applied for a phase 3 trial of the autoimmune disease drug HL161 (ingredient: batoclimab) in Japan.In a public disclosure on Friday, HanAll said it submitted Clinical Trial Notification (CTN) for the phase 3 study of HL161 to treat myasthenia gravis (MG) in Japan.Japan’s
Peptron said Monday that it has received phase 3 IND approval from the U.S. FDA for its proprietary ultrasonic spray drying SmartDepot technology as a cerebrovascular therapeutic, Presedin (PT320), being co-developed with Invex.PT320 implements an ideal drug release pattern for therapeutic effects a
Korea’s biopharmaceutical companies and diagnosis kit makers showed mixed performances in the second quarter, depending on their CMO (contract manufacturing organization) businesses and the spreading curve of Covid-19, industry watchers said Friday.Samsung Biologics and Celltrion Healthcare stood ou
Celltrion said it signed a contract manufacturing organization (CMO) contract with Teva Pharmaceutical to supply raw materials for Ajovy, a migraine drug.The contract is worth about 110 billion won ($82.8 million), 5.8 percent of Celltrion’s 2021 sales and its period is from Aug. 19, 2022, to March